This finding is relevant for the interpretation of the link between TFIIH and the p53 and JNK pathways in the generation and treatment of cancer and confirmed that the inhibition of ATPase activity by triptolide causes defects identical to those observed in TFIIH mutants [36]. The gene discussed is ERCC2; the disease is cancer.